Towards safe abortion access: an exploratory study of medical abortion in Cambodia.
Identifieur interne : 002542 ( PubMed/Checkpoint ); précédent : 002541; suivant : 002543Towards safe abortion access: an exploratory study of medical abortion in Cambodia.
Auteurs : Pascale Hancart Petitet [France] ; Leakhena Ith [Cambodge] ; Melissa Cockroft [Australie] ; Thérèse Delvaux [Belgique]Source :
- Reproductive health matters [ 1460-9576 ] ; 2015.
Descripteurs français
- KwdFr :
- Abortifs non stéroïdiens (usage thérapeutique), Abortifs stéroïdiens (usage thérapeutique), Accessibilité des services de santé, Adulte, Association médicamenteuse, Avortement provoqué (), Avortement provoqué (psychologie), Cambodge, Connaissances, attitudes et pratiques en santé, Femelle, Grossesse, Humains, Jeune adulte, Mifépristone (usage thérapeutique), Misoprostol (usage thérapeutique), Mâle, Partenaire sexuel (psychologie), Pharmaciens (psychologie), Satisfaction du patient, Établissements de soins ambulatoires (utilisation).
- MESH :
- psychologie : Avortement provoqué, Partenaire sexuel, Pharmaciens.
- usage thérapeutique : Abortifs non stéroïdiens, Abortifs stéroïdiens, Mifépristone, Misoprostol.
- utilisation : Établissements de soins ambulatoires.
- Accessibilité des services de santé, Adulte, Association médicamenteuse, Avortement provoqué, Cambodge, Connaissances, attitudes et pratiques en santé, Femelle, Grossesse, Humains, Jeune adulte, Mâle, Satisfaction du patient.
English descriptors
- KwdEn :
- Abortifacient Agents, Nonsteroidal (therapeutic use), Abortifacient Agents, Steroidal (therapeutic use), Abortion, Induced (methods), Abortion, Induced (psychology), Adult, Ambulatory Care Facilities (utilization), Cambodia, Drug Combinations, Female, Health Knowledge, Attitudes, Practice, Health Services Accessibility, Humans, Male, Mifepristone (therapeutic use), Misoprostol (therapeutic use), Patient Satisfaction, Pharmacists (psychology), Pregnancy, Sexual Partners (psychology), Young Adult.
- MESH :
- chemical , therapeutic use : Abortifacient Agents, Nonsteroidal, Abortifacient Agents, Steroidal, Mifepristone, Misoprostol.
- methods : Abortion, Induced.
- psychology : Abortion, Induced, Pharmacists, Sexual Partners.
- utilization : Ambulatory Care Facilities.
- Adult, Cambodia, Drug Combinations, Female, Health Knowledge, Attitudes, Practice, Health Services Accessibility, Humans, Male, Patient Satisfaction, Pregnancy, Young Adult.
Abstract
In 2010, following its approval by the Ministry of Health, the medical abortion combination pack Medabon (containing mifepristone and misoprostol) was made available at pharmacies and in a restricted number of health facilities in Cambodia. The qualitative study presented in this paper was conducted in 2012 as a follow-up to longer-term ethnographical research related to reproductive health and fertility regulation between 2008 and 2012. Observations were carried out at several clinic and pharmacy sites and in-depth interviews were conducted with a purposive sample of 20 women who attended two MSI Cambodia centres and 10 women identified through social networks; six men (women's male partners); eight health care providers at the two MSI centres and four pill sellers at private or informal pharmacies (who also provided health care services in private clinics). Although the level of training among the drug sellers and providers varied, their knowledge about medical abortion regimens, correct usage and common side effects was good. Overall, women were satisfied with the services provided. Medical abortion was not always a women-only process in this study as some male partners were also involved in the care process. The study illustrates positive steps forward being taken in making abortion safe and preventing and reducing unsafe abortion practices in Cambodia.
DOI: 10.1016/S0968-8080(14)43826-6
PubMed: 25702068
Affiliations:
- Australie, Belgique, Cambodge, France
- Languedoc-Roussillon, Occitanie (région administrative)
- Montpellier
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:25702068Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Towards safe abortion access: an exploratory study of medical abortion in Cambodia.</title><author><name sortKey="Petitet, Pascale Hancart" sort="Petitet, Pascale Hancart" uniqKey="Petitet P" first="Pascale Hancart" last="Petitet">Pascale Hancart Petitet</name><affiliation wicri:level="3"><nlm:affiliation>Researcher, Institut de Recherche pour le Développement, Montpellier, France. Electronic address: pascale.hancart-petitet@ird.fr.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Researcher, Institut de Recherche pour le Développement, Montpellier</wicri:regionArea><placeName><region type="region">Occitanie (région administrative)</region><region type="old region">Languedoc-Roussillon</region><settlement type="city">Montpellier</settlement></placeName></affiliation></author><author><name sortKey="Ith, Leakhena" sort="Ith, Leakhena" uniqKey="Ith L" first="Leakhena" last="Ith">Leakhena Ith</name><affiliation wicri:level="1"><nlm:affiliation>International Executive Service Corps, and former Master's student, Royal University of Phnom Penh, Phnom Penh, Cambodia.</nlm:affiliation><country xml:lang="fr">Cambodge</country><wicri:regionArea>International Executive Service Corps, and former Master's student, Royal University of Phnom Penh, Phnom Penh</wicri:regionArea><wicri:noRegion>Phnom Penh</wicri:noRegion></affiliation></author><author><name sortKey="Cockroft, Melissa" sort="Cockroft, Melissa" uniqKey="Cockroft M" first="Melissa" last="Cockroft">Melissa Cockroft</name><affiliation wicri:level="1"><nlm:affiliation>Technical Advisor on Reproductive Health, Cambodia, Australian National University, Canberra, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Technical Advisor on Reproductive Health, Cambodia, Australian National University, Canberra</wicri:regionArea><wicri:noRegion>Canberra</wicri:noRegion></affiliation></author><author><name sortKey="Delvaux, Therese" sort="Delvaux, Therese" uniqKey="Delvaux T" first="Thérèse" last="Delvaux">Thérèse Delvaux</name><affiliation wicri:level="1"><nlm:affiliation>Researcher, Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Researcher, Department of Public Health, Institute of Tropical Medicine, Antwerp</wicri:regionArea><wicri:noRegion>Antwerp</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:25702068</idno><idno type="pmid">25702068</idno><idno type="doi">10.1016/S0968-8080(14)43826-6</idno><idno type="wicri:Area/PubMed/Corpus">003000</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003000</idno><idno type="wicri:Area/PubMed/Curation">002F19</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002F19</idno><idno type="wicri:Area/PubMed/Checkpoint">002F19</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002F19</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Towards safe abortion access: an exploratory study of medical abortion in Cambodia.</title><author><name sortKey="Petitet, Pascale Hancart" sort="Petitet, Pascale Hancart" uniqKey="Petitet P" first="Pascale Hancart" last="Petitet">Pascale Hancart Petitet</name><affiliation wicri:level="3"><nlm:affiliation>Researcher, Institut de Recherche pour le Développement, Montpellier, France. Electronic address: pascale.hancart-petitet@ird.fr.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Researcher, Institut de Recherche pour le Développement, Montpellier</wicri:regionArea><placeName><region type="region">Occitanie (région administrative)</region><region type="old region">Languedoc-Roussillon</region><settlement type="city">Montpellier</settlement></placeName></affiliation></author><author><name sortKey="Ith, Leakhena" sort="Ith, Leakhena" uniqKey="Ith L" first="Leakhena" last="Ith">Leakhena Ith</name><affiliation wicri:level="1"><nlm:affiliation>International Executive Service Corps, and former Master's student, Royal University of Phnom Penh, Phnom Penh, Cambodia.</nlm:affiliation><country xml:lang="fr">Cambodge</country><wicri:regionArea>International Executive Service Corps, and former Master's student, Royal University of Phnom Penh, Phnom Penh</wicri:regionArea><wicri:noRegion>Phnom Penh</wicri:noRegion></affiliation></author><author><name sortKey="Cockroft, Melissa" sort="Cockroft, Melissa" uniqKey="Cockroft M" first="Melissa" last="Cockroft">Melissa Cockroft</name><affiliation wicri:level="1"><nlm:affiliation>Technical Advisor on Reproductive Health, Cambodia, Australian National University, Canberra, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Technical Advisor on Reproductive Health, Cambodia, Australian National University, Canberra</wicri:regionArea><wicri:noRegion>Canberra</wicri:noRegion></affiliation></author><author><name sortKey="Delvaux, Therese" sort="Delvaux, Therese" uniqKey="Delvaux T" first="Thérèse" last="Delvaux">Thérèse Delvaux</name><affiliation wicri:level="1"><nlm:affiliation>Researcher, Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Researcher, Department of Public Health, Institute of Tropical Medicine, Antwerp</wicri:regionArea><wicri:noRegion>Antwerp</wicri:noRegion></affiliation></author></analytic><series><title level="j">Reproductive health matters</title><idno type="eISSN">1460-9576</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Abortifacient Agents, Nonsteroidal (therapeutic use)</term><term>Abortifacient Agents, Steroidal (therapeutic use)</term><term>Abortion, Induced (methods)</term><term>Abortion, Induced (psychology)</term><term>Adult</term><term>Ambulatory Care Facilities (utilization)</term><term>Cambodia</term><term>Drug Combinations</term><term>Female</term><term>Health Knowledge, Attitudes, Practice</term><term>Health Services Accessibility</term><term>Humans</term><term>Male</term><term>Mifepristone (therapeutic use)</term><term>Misoprostol (therapeutic use)</term><term>Patient Satisfaction</term><term>Pharmacists (psychology)</term><term>Pregnancy</term><term>Sexual Partners (psychology)</term><term>Young Adult</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Abortifs non stéroïdiens (usage thérapeutique)</term><term>Abortifs stéroïdiens (usage thérapeutique)</term><term>Accessibilité des services de santé</term><term>Adulte</term><term>Association médicamenteuse</term><term>Avortement provoqué ()</term><term>Avortement provoqué (psychologie)</term><term>Cambodge</term><term>Connaissances, attitudes et pratiques en santé</term><term>Femelle</term><term>Grossesse</term><term>Humains</term><term>Jeune adulte</term><term>Mifépristone (usage thérapeutique)</term><term>Misoprostol (usage thérapeutique)</term><term>Mâle</term><term>Partenaire sexuel (psychologie)</term><term>Pharmaciens (psychologie)</term><term>Satisfaction du patient</term><term>Établissements de soins ambulatoires (utilisation)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Abortifacient Agents, Nonsteroidal</term><term>Abortifacient Agents, Steroidal</term><term>Mifepristone</term><term>Misoprostol</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Abortion, Induced</term></keywords><keywords scheme="MESH" qualifier="psychologie" xml:lang="fr"><term>Avortement provoqué</term><term>Partenaire sexuel</term><term>Pharmaciens</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Abortion, Induced</term><term>Pharmacists</term><term>Sexual Partners</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Abortifs non stéroïdiens</term><term>Abortifs stéroïdiens</term><term>Mifépristone</term><term>Misoprostol</term></keywords><keywords scheme="MESH" qualifier="utilisation" xml:lang="fr"><term>Établissements de soins ambulatoires</term></keywords><keywords scheme="MESH" qualifier="utilization" xml:lang="en"><term>Ambulatory Care Facilities</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Cambodia</term><term>Drug Combinations</term><term>Female</term><term>Health Knowledge, Attitudes, Practice</term><term>Health Services Accessibility</term><term>Humans</term><term>Male</term><term>Patient Satisfaction</term><term>Pregnancy</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Accessibilité des services de santé</term><term>Adulte</term><term>Association médicamenteuse</term><term>Avortement provoqué</term><term>Cambodge</term><term>Connaissances, attitudes et pratiques en santé</term><term>Femelle</term><term>Grossesse</term><term>Humains</term><term>Jeune adulte</term><term>Mâle</term><term>Satisfaction du patient</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In 2010, following its approval by the Ministry of Health, the medical abortion combination pack Medabon (containing mifepristone and misoprostol) was made available at pharmacies and in a restricted number of health facilities in Cambodia. The qualitative study presented in this paper was conducted in 2012 as a follow-up to longer-term ethnographical research related to reproductive health and fertility regulation between 2008 and 2012. Observations were carried out at several clinic and pharmacy sites and in-depth interviews were conducted with a purposive sample of 20 women who attended two MSI Cambodia centres and 10 women identified through social networks; six men (women's male partners); eight health care providers at the two MSI centres and four pill sellers at private or informal pharmacies (who also provided health care services in private clinics). Although the level of training among the drug sellers and providers varied, their knowledge about medical abortion regimens, correct usage and common side effects was good. Overall, women were satisfied with the services provided. Medical abortion was not always a women-only process in this study as some male partners were also involved in the care process. The study illustrates positive steps forward being taken in making abortion safe and preventing and reducing unsafe abortion practices in Cambodia.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25702068</PMID><DateCreated><Year>2015</Year><Month>02</Month><Day>23</Day></DateCreated><DateCompleted><Year>2017</Year><Month>01</Month><Day>05</Day></DateCompleted><DateRevised><Year>2017</Year><Month>01</Month><Day>06</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1460-9576</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>44 Suppl 1</Issue><PubDate><Year>2015</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Reproductive health matters</Title><ISOAbbreviation>Reprod Health Matters</ISOAbbreviation></Journal><ArticleTitle>Towards safe abortion access: an exploratory study of medical abortion in Cambodia.</ArticleTitle><Pagination><MedlinePgn>47-55</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/S0968-8080(14)43826-6</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0968-8080(14)43826-6</ELocationID><Abstract><AbstractText>In 2010, following its approval by the Ministry of Health, the medical abortion combination pack Medabon (containing mifepristone and misoprostol) was made available at pharmacies and in a restricted number of health facilities in Cambodia. The qualitative study presented in this paper was conducted in 2012 as a follow-up to longer-term ethnographical research related to reproductive health and fertility regulation between 2008 and 2012. Observations were carried out at several clinic and pharmacy sites and in-depth interviews were conducted with a purposive sample of 20 women who attended two MSI Cambodia centres and 10 women identified through social networks; six men (women's male partners); eight health care providers at the two MSI centres and four pill sellers at private or informal pharmacies (who also provided health care services in private clinics). Although the level of training among the drug sellers and providers varied, their knowledge about medical abortion regimens, correct usage and common side effects was good. Overall, women were satisfied with the services provided. Medical abortion was not always a women-only process in this study as some male partners were also involved in the care process. The study illustrates positive steps forward being taken in making abortion safe and preventing and reducing unsafe abortion practices in Cambodia.</AbstractText><CopyrightInformation>Copyright © 2015 Reproductive Health Matters. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Petitet</LastName><ForeName>Pascale Hancart</ForeName><Initials>PH</Initials><AffiliationInfo><Affiliation>Researcher, Institut de Recherche pour le Développement, Montpellier, France. Electronic address: pascale.hancart-petitet@ird.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ith</LastName><ForeName>Leakhena</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>International Executive Service Corps, and former Master's student, Royal University of Phnom Penh, Phnom Penh, Cambodia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cockroft</LastName><ForeName>Melissa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Technical Advisor on Reproductive Health, Cambodia, Australian National University, Canberra, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delvaux</LastName><ForeName>Thérèse</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Researcher, Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Reprod Health Matters</MedlineTA><NlmUniqueID>9420826</NlmUniqueID><ISSNLinking>0968-8080</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000020">Abortifacient Agents, Nonsteroidal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000021">Abortifacient Agents, Steroidal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004338">Drug Combinations</NameOfSubstance></Chemical><Chemical><RegistryNumber>0E43V0BB57</RegistryNumber><NameOfSubstance UI="D016595">Misoprostol</NameOfSubstance></Chemical><Chemical><RegistryNumber>320T6RNW1F</RegistryNumber><NameOfSubstance UI="D015735">Mifepristone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000020" MajorTopicYN="N">Abortifacient Agents, Nonsteroidal</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000021" MajorTopicYN="N">Abortifacient Agents, Steroidal</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000028" MajorTopicYN="N">Abortion, Induced</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000554" MajorTopicYN="N">Ambulatory Care Facilities</DescriptorName><QualifierName UI="Q000656" MajorTopicYN="N">utilization</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002160" MajorTopicYN="N">Cambodia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004338" MajorTopicYN="N">Drug Combinations</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007722" MajorTopicYN="N">Health Knowledge, Attitudes, Practice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006297" MajorTopicYN="N">Health Services Accessibility</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015735" MajorTopicYN="N">Mifepristone</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016595" MajorTopicYN="N">Misoprostol</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017060" MajorTopicYN="N">Patient Satisfaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010595" MajorTopicYN="N">Pharmacists</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012747" MajorTopicYN="N">Sexual Partners</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cambodia</Keyword><Keyword MajorTopicYN="N">abortion providers</Keyword><Keyword MajorTopicYN="N">medical abortion</Keyword><Keyword MajorTopicYN="N">mifepristone</Keyword><Keyword MajorTopicYN="N">misoprostol</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25702068</ArticleId><ArticleId IdType="pii">S0968-8080(14)43826-6</ArticleId><ArticleId IdType="doi">10.1016/S0968-8080(14)43826-6</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Australie</li><li>Belgique</li><li>Cambodge</li><li>France</li></country><region><li>Languedoc-Roussillon</li><li>Occitanie (région administrative)</li></region><settlement><li>Montpellier</li></settlement></list><tree><country name="France"><region name="Occitanie (région administrative)"><name sortKey="Petitet, Pascale Hancart" sort="Petitet, Pascale Hancart" uniqKey="Petitet P" first="Pascale Hancart" last="Petitet">Pascale Hancart Petitet</name></region></country><country name="Cambodge"><noRegion><name sortKey="Ith, Leakhena" sort="Ith, Leakhena" uniqKey="Ith L" first="Leakhena" last="Ith">Leakhena Ith</name></noRegion></country><country name="Australie"><noRegion><name sortKey="Cockroft, Melissa" sort="Cockroft, Melissa" uniqKey="Cockroft M" first="Melissa" last="Cockroft">Melissa Cockroft</name></noRegion></country><country name="Belgique"><noRegion><name sortKey="Delvaux, Therese" sort="Delvaux, Therese" uniqKey="Delvaux T" first="Thérèse" last="Delvaux">Thérèse Delvaux</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002542 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 002542 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:25702068
|texte= Towards safe abortion access: an exploratory study of medical abortion in Cambodia.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:25702068" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |